Matthew Wagoner

Matthew Wagoner

Company: Takeda

Job title: Director of Investigative Toxicology


Matt Wagoner leads the Global Investigatory Toxicology team at Takeda Pharmaceuticals, where their team applies complex in vitro models and in silico approaches as predictive and mechanistic tools to help make safer medicines.  Before Takeda, Matt led the mRNA safety strategy for AstraZeneca Pharmaceuticals, and worked to develop and deploy in vitro and in vivo models in support of oncology and cardiovascular drug discovery projects.

In the academic arena, Matt co-taught a drug discovery course at Simmons College in Boston.  He received his PhD in Molecular and Cellular Pharmacology from the University of Wisconsin-Madison and bachelors in biochemistry from the University of Illinois Urbana Champaign.

In lieu of hobbies, Matt has four kids and a debilitating addiction to home improvement projects.


Surviving the Technology Hype Cycle: Where MPS Are Having an Impact Today & Where They Are Needed Next 11:40 am

• Understand how to utilize MPS models successfully in your preclinical studies • Look into the future to see how MPS can have the greatest impactRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.